Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75b30ff8273a54b655e5eb2eed62b4b1 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10345 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0058 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 |
filingDate |
2004-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2009-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce2d6cb154ce28d40dbb75de7fcab2f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f35593413f3f21f531144e8f3e4a42c |
publicationDate |
2009-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7575919-B2 |
titleOfInvention |
Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
abstract |
The present invention provides adenoviral vectors comprising cell status-specific transcriptional regulatory elements which confer cell status-specific transcriptional regulation on an adenoviral gene. A “cell status” is generally a reversible physiological and/or environmental state. The invention further provides compositions and host cells comprising the vectors, as well as methods of using the vectors. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013323206-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103314107-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103314107-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012046943-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9689000-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE42373-E http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101232123-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11596660-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11497781-B2 |
priorityDate |
1998-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |